Extract Data examples by discipline
Ready-to-copy field sets for twelve research disciplines — from clinical medicine and public health to computer science, engineering, and economics.
Copy a set, then edit the wording to match your corpus. Type is the output structure: Answer, Yes/Maybe/No, or Specified with the choice list shown. For the full overview of what you can do with Extract Data — twelve field families, fifteen use cases, and four starter packs — see What you can do with Extract Data. For how to word a field, see Tips for creating better extraction fields.
1. Clinical medicine — intervention trials
Example topic: Effect of early mobilisation on ICU length of stay.
| Field | Type | Instructions |
|---|---|---|
| Study design | Specified — RCT, Cluster RCT, Non-randomised trial, Prospective cohort, Retrospective cohort, Case-control, Before-after | Classify the design as the authors label it. Pick the single best fit. |
| Analysed sample | Answer | Number of participants in the primary analysis, not screened or randomised. Total first, per-arm in parentheses if reported. Format: "294 (148/146)". |
| Population | Answer | Who was studied: condition, mean or median age with its spread, and % female, exactly as printed. Format: "Mechanically ventilated ICU adults; mean age 62.4 (SD 14.1); 41% female". |
| Intervention | Answer | What the intervention group received: what was done, how often, for how long, and by whom. Format: "Progressive mobilisation, twice daily, from ICU day 1, physiotherapist-delivered". |
| Comparator | Answer | What the control group received, in the authors' words. If usual care, say what usual care included if described. |
| Primary outcome | Answer | The outcome the authors designate as primary, and how it was measured. Do not list secondary outcomes here. |
| Primary result | Answer | The effect on the primary outcome with its 95% CI and p-value exactly as printed, naming the metric. Format: "MD −1.9 days (95% CI −3.1 to −0.7), p=0.002". |
| Follow-up | Answer | Longest timepoint at which outcomes were measured, in the paper's unit. Format: "90 days". |
| Adverse events | Answer | Serious adverse events with denominators, per arm, exactly as printed. Do not convert counts to percentages. If none reported, answer "Not reported". |
| Author limitations | Answer | Limitations the authors state themselves, one short bullet each. Do not add your own. |
2. Public health & epidemiology
Example topic: Air pollution exposure and childhood asthma incidence.
| Field | Type | Instructions |
|---|---|---|
| Study design | Specified — Prospective cohort, Retrospective cohort, Case-control, Cross-sectional, Ecological, Time-series | Classify the design as the authors describe it. |
| Exposure measure | Answer | The pollutant and how exposure was assigned: monitoring station, land-use regression, satellite, personal monitor. Include averaging period. Format: "PM2.5, land-use regression, annual mean". |
| Outcome definition | Answer | How the health outcome was defined and ascertained: diagnosis code, registry, parent report, spirometry. |
| Population and setting | Answer | Age range, country or city, and cohort name if any. Format: "Children 0–12 y; Barcelona, Spain; INMA cohort". |
| Sample size | Answer | Number of individuals in the analysis, and person-years if reported. Format: "3,412 children; 28,700 person-years". |
| Confounders adjusted | Answer | Variables in the fully adjusted model, listed as printed. Format: comma-separated list. |
| Effect estimate | Answer | Effect for the main exposure–outcome pair, with metric, per-unit increment, and 95% CI exactly as printed. Format: "HR 1.13 (95% CI 1.04–1.22) per 5 µg/m³ PM2.5". |
| Study period | Answer | Calendar years of data collection. Format: "2008–2016". |
3. Pharmacology & drug safety
Example topic: Adverse events reported for GLP-1 receptor agonists.
| Field | Type | Instructions |
|---|---|---|
| Drug and dose | Answer | Drug studied with dose and schedule exactly as reported. Format: "Semaglutide 2.4 mg once weekly, subcutaneous". |
| Indication | Answer | The condition treated as stated by the authors. |
| Data source | Specified — RCT, Observational cohort, Spontaneous reports / pharmacovigilance, Claims database, Registry, Case report | Classify where the safety data came from. |
| Exposure period | Answer | Treatment duration and total exposure if reported. Format: "68 weeks; 1,961 patient-years". |
| Adverse events reported | Answer | All adverse events the paper reports with incidence, one bullet each, with denominators as printed. |
| Serious adverse events | Answer | Serious adverse events with denominators per arm, exactly as printed. If none, answer "Not reported". |
| Discontinuations | Answer | Number discontinuing due to adverse events, with denominator, per arm. Format: "70/1306 (5.4%) vs 15/652 (2.3%)". |
| Signal noted | Yes/Maybe/No | Do the authors identify a new or unexpected safety signal? yes only if they explicitly say so. no if no new or unexpected signal is described anywhere. maybe if a potential signal is discussed only tentatively. |
| Funding source | Specified — Industry, Public/government, Charity/foundation, Mixed, None stated | Classify the funding as stated in the funding or COI section. |
4. HEOR & health economics
Example topic: Cost-effectiveness of biologics in rheumatoid arthritis.
| Field | Type | Instructions |
|---|---|---|
| Model type | Specified — Markov, Decision tree, Discrete event simulation, Partitioned survival, Trial-based analysis, Other model | Classify the economic model structure as described. |
| Perspective | Specified — Healthcare payer, Societal, Provider, Patient, Multiple | Classify the stated analytic perspective. |
| Comparators | Answer | Interventions compared, one short bullet each, in the authors' wording. |
| Time horizon | Answer | The base-case time horizon exactly as stated. Format: "Lifetime (50 years)". |
| Discount rate | Answer | Discount rates for costs and outcomes as stated. Format: "3.5% costs, 3.5% outcomes". |
| Cost year and currency | Answer | Price year and currency of reported costs. Do not convert. Format: "2022 GBP". |
| Utility source | Answer | Where utility values came from: instrument, population, and citation as described. Format: "EQ-5D-3L, UK tariff, from trial data". |
| ICER | Answer | Base-case incremental cost-effectiveness ratio with currency, price year, and unit. Format: "£24,300 per QALY (2022 GBP)". |
| Sensitivity analysis | Answer | Which parameters drove the result in one-way or probabilistic sensitivity analysis, as the authors report. |
| Conclusion | Specified — Cost-effective at stated threshold, Not cost-effective, Dominant, Dominated, Mixed by subgroup | Classify the authors' base-case conclusion. |
5. Medical devices, diagnostics & regulatory evidence
Example topic: Clinical performance of point-of-care troponin assays.
| Field | Type | Instructions |
|---|---|---|
| Device or assay | Answer | Name and manufacturer of the device or assay evaluated, exactly as printed. |
| Indication and use | Answer | Clinical question and setting in which the device was used. Format: "Rule-out of MI in ED chest pain presentations". |
| Reference standard | Answer | The comparator standard against which performance was judged, as described. |
| Sample size | Answer | Number of patients or specimens in the performance analysis, with the number of positives if reported. Format: "1,282 patients; 145 MI-positive". |
| Sensitivity | Answer | Sensitivity with 95% CI exactly as printed, at the stated threshold. Format: "98.6% (95% CI 95.1–99.8) at 5 ng/L". |
| Specificity | Answer | Specificity with 95% CI exactly as printed, at the same threshold. |
| Adverse events / safety | Answer | Device-related adverse events or safety findings reported. If the study reports none, answer "Not reported". |
| Favourable outcomes | Answer | Findings the authors present as supporting device performance, one bullet each. |
| Unfavourable outcomes | Answer | Findings the authors present as limitations of device performance, one bullet each. |
| Funding / sponsor | Specified — Manufacturer-funded, Independent/public, Mixed, None stated | Classify funding as stated. |
6. Psychology & behavioural science
Example topic: Efficacy of CBT for adolescent anxiety.
| Field | Type | Instructions |
|---|---|---|
| Design | Specified — RCT, Quasi-experimental, Single-group pre-post, Cross-sectional, Longitudinal observational | Classify the design as the authors describe it. |
| Age range | Answer | Age range and mean age of participants exactly as printed. Format: "12–17 y; mean 14.3 (SD 1.6)". |
| Outcome instrument | Answer | The named scale used for the primary outcome, with version and scoring range if stated. Format: "SCARED, child version, 0–82". |
| Delivery format | Specified — Individual in-person, Group in-person, Therapist-guided digital, Self-guided digital, Blended | Classify how the intervention was delivered. |
| Dose | Answer | Number of sessions and session length as reported. Format: "12 sessions × 50 min over 14 weeks". |
| Control condition | Answer | What the comparison group received: waitlist, treatment as usual, active control, placebo. |
| Effect size | Answer | Between-group effect size for the primary outcome with 95% CI, naming the metric. Format: "Hedges' g −0.61 (95% CI −0.92 to −0.30)". |
| Attrition | Answer | Number and percentage lost to follow-up, per arm if reported. Format: "18/94 (19%) vs 11/91 (12%)". |
| Preregistered | Yes/Maybe/No | Does the paper state that the study or analysis plan was preregistered? yes only if a registry or ID is given. no if no registration statement or ID appears anywhere. maybe if registration is mentioned without an identifier. |
7. Computer science & machine learning
Example topic: Retrieval-augmented generation methods on open-domain QA.
| Field | Type | Instructions |
|---|---|---|
| Method name | Answer | The name the authors give their proposed method or model. Format: name only. |
| Architecture | Answer | Model architecture and size, and the base model it builds on. Format: "Decoder-only, 7B, Llama-2 base". |
| Task and dataset | Answer | Task addressed and the datasets evaluated on, as named by the authors. Format: comma-separated dataset names. |
| Training data | Answer | Data used for training or fine-tuning, with size, exactly as reported. If the model is used zero-shot, answer "Not applicable". |
| Primary metric | Specified — Accuracy, F1, Exact match, BLEU/ROUGE, AUC, Human evaluation, Other | Classify the headline metric the authors emphasise. |
| Best result | Answer | Highest score the authors report for their method on the primary benchmark, with the metric and dataset. Copy decimals exactly. Format: "54.2 EM (NQ)". |
| Baselines compared | Answer | Baselines the method is compared against, one short bullet each, with their reported scores if given. |
| Ablations run | Answer | Ablation studies reported and what each removed, one bullet each. If none, answer "Not reported". |
| Compute reported | Answer | Hardware and training or inference cost as reported. Format: "8× A100 80GB, 36 GPU-hours". If not stated, answer "Not reported". |
| Code available | Yes/Maybe/No | Does the paper state that code is publicly available? yes only if a repository link or explicit availability statement is given. no if no code-availability statement or link appears anywhere, including footnotes and appendix. maybe if code is available on request or promised for later release. |
8. Engineering & materials science
Example topic: Mechanical properties of recycled PET composites.
| Field | Type | Instructions |
|---|---|---|
| Material system | Answer | Matrix and reinforcement with weight or volume fractions exactly as printed. Format: "rPET + 20 wt% short glass fibre". |
| Processing method | Answer | How specimens were produced, with key parameters. Format: "Twin-screw extrusion, 265 °C, then injection moulding". |
| Test standard | Answer | The standard followed for the primary test, exactly as cited. Format: "ASTM D638 Type I". |
| Specimens tested | Answer | Number of specimens per condition, as reported. Format: "n=5 per condition". |
| Tensile strength | Answer | Tensile strength for the primary composition, with unit and standard deviation as printed. Do not convert units. Format: "48.2 ± 2.1 MPa". |
| Modulus | Answer | Young's modulus for the same composition, with unit and spread as printed. |
| Test conditions | Answer | Temperature, humidity, strain rate, and conditioning as reported. |
| Comparison to virgin material | Yes/Maybe/No | Does the paper compare the recycled material against a virgin-material control? yes if a virgin-material control is tested or reported alongside. no if no such comparison appears anywhere in the results. maybe if compared only against literature values. |
9. Environmental science & ecology
Example topic: Effectiveness of marine protected areas on fish biomass.
| Field | Type | Instructions |
|---|---|---|
| Location | Answer | Study location with country and named site or region. Format: "Medes Islands, Spain (NW Mediterranean)". |
| Protection level | Specified — No-take reserve, Partially protected, Multi-use, Unprotected control, Mixed | Classify the protection status studied. |
| Time since designation | Answer | Years between protection designation and data collection, as reported. Format: "18 years". |
| Sampling method | Answer | How the outcome was measured, with effort. Format: "Underwater visual census, 50 × 5 m transects, n=120". |
| Outcome measured | Answer | The ecological outcome and its unit exactly as reported. Format: "Total fish biomass, g/m²". |
| Effect reported | Answer | Difference between protected and control, with metric and uncertainty exactly as printed. Format: "+3.1× biomass inside reserve (95% CI 2.2–4.4)". |
| Confounders addressed | Answer | Habitat, depth, or fishing-pressure differences the authors control for, as described. If not addressed, answer "Not reported". |
10. Education
Example topic: Impact of flipped classrooms on student outcomes.
| Field | Type | Instructions |
|---|---|---|
| Education level | Specified — Primary, Secondary, Undergraduate, Postgraduate, Professional/CPD, Mixed | Classify the level of the learners studied. |
| Subject area | Answer | The subject or course in which the intervention was delivered, as named. |
| Design | Specified — RCT, Quasi-experimental with control, Pre-post single group, Cross-sectional survey, Qualitative | Classify the study design. |
| Sample | Answer | Number of students analysed, and number of classes or institutions if reported. Format: "412 students, 6 sections, 1 university". |
| Implementation length | Answer | How long the intervention ran, in the paper's unit. Format: "One 15-week semester". |
| Outcome measure | Answer | How learning was measured: exam score, standardised test, grade, self-report scale. Name the instrument. |
| Effect on outcome | Answer | Difference between conditions with effect size and CI or p-value exactly as printed. |
| Control condition | Answer | What the comparison group experienced, in the authors' words. |
| Fidelity reported | Yes/Maybe/No | Does the paper report whether the intervention was implemented as designed? yes if fidelity or adherence data is reported. no if implementation fidelity is not mentioned anywhere. maybe if fidelity is discussed without data. |
11. Qualitative research & implementation science
Example topic: Barriers to telehealth uptake among older adults.
| Field | Type | Instructions |
|---|---|---|
| Method | Specified — Semi-structured interviews, Focus groups, Ethnography/observation, Document analysis, Mixed qualitative | Classify the primary data-collection method. |
| Theoretical framework | Answer | The named theory, model, or framework guiding the study. If none is named, answer "Not reported". |
| Participants | Answer | Who took part, how many, and how they were recruited. Format: "24 adults aged 68–91, purposive sampling from 3 primary care practices". |
| Setting | Answer | Where the study took place: country, service, and context. |
| Analysis approach | Answer | The analytic method as named, with any coding procedure described. Format: "Reflexive thematic analysis, two coders, NVivo". |
| Themes identified | Answer | The themes the authors report, one short bullet each, in the authors' own labels. |
| Barriers reported | Answer | Barriers the authors identify, one short bullet each. Include only barriers this study found. |
| Facilitators reported | Answer | Facilitators the authors identify, one short bullet each. If none, answer "Not reported". |
| Saturation reported | Yes/Maybe/No | Do the authors state that data saturation was reached? yes only if explicitly stated. no if saturation is not mentioned anywhere. maybe if implied (e.g. "no new themes emerged") without the term. |
| Ethics approval | Answer | The ethics committee and approval reference exactly as printed. If absent, answer "Not reported". |
12. Economics, business & policy
Example topic: Minimum wage effects on employment.
| Field | Type | Instructions |
|---|---|---|
| Jurisdiction and period | Answer | Geography and years covered by the analysis. Format: "United States, 1990–2019, state-level". |
| Data source | Answer | The dataset used, named exactly, with its unit of observation. Format: "QCEW, county-quarter". |
| Identification strategy | Specified — Difference-in-differences, Synthetic control, Instrumental variables, Regression discontinuity, Event study, OLS/descriptive | Classify the main identification approach. |
| Treatment definition | Answer | How the policy or treatment is defined and measured in the analysis. |
| Outcome variable | Answer | The dependent variable and its unit exactly as defined. Format: "Log teen employment rate". |
| Main estimate | Answer | The headline coefficient with its standard error or CI exactly as printed, naming the specification. Format: "−0.021 (SE 0.014), preferred DiD specification". |
| Robustness checks | Answer | Robustness or placebo tests reported, one short bullet each. |
| Data/code available | Yes/Maybe/No | Does the paper state that replication data or code is available? yes if an availability statement or link is given. no if no such statement appears anywhere. maybe if available on request. |
See also
- What you can do with Extract Data — twelve field families, fifteen use cases, and four starter packs
- Tips for creating better extraction fields